Keywords: r-pr, submits, first, licence, application, irinotecan, rhone-poulenc

R-PR Submits First Licence Application For Irinotecan

Article | 02 January 1995

Rhone-Poulenc Rorer has submitted a license application to the French regulatory authorities for its anticancer drug irinotecan (also known as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Carac

Fluorouracil

Efudex

Go to drug listing